Correlation Between Stereotaxis and Predictive Oncology
Can any of the company-specific risk be diversified away by investing in both Stereotaxis and Predictive Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Stereotaxis and Predictive Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Stereotaxis and Predictive Oncology, you can compare the effects of market volatilities on Stereotaxis and Predictive Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Stereotaxis with a short position of Predictive Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Stereotaxis and Predictive Oncology.
Diversification Opportunities for Stereotaxis and Predictive Oncology
0.66 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Stereotaxis and Predictive is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Stereotaxis and Predictive Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Predictive Oncology and Stereotaxis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Stereotaxis are associated (or correlated) with Predictive Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Predictive Oncology has no effect on the direction of Stereotaxis i.e., Stereotaxis and Predictive Oncology go up and down completely randomly.
Pair Corralation between Stereotaxis and Predictive Oncology
Given the investment horizon of 90 days Stereotaxis is expected to generate 0.41 times more return on investment than Predictive Oncology. However, Stereotaxis is 2.46 times less risky than Predictive Oncology. It trades about 0.04 of its potential returns per unit of risk. Predictive Oncology is currently generating about -0.03 per unit of risk. If you would invest 201.00 in Stereotaxis on August 28, 2024 and sell it today you would earn a total of 25.00 from holding Stereotaxis or generate 12.44% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Stereotaxis vs. Predictive Oncology
Performance |
| Timeline |
| Stereotaxis |
| Predictive Oncology |
Stereotaxis and Predictive Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Stereotaxis and Predictive Oncology
The main advantage of trading using opposite Stereotaxis and Predictive Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Stereotaxis position performs unexpectedly, Predictive Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Predictive Oncology will offset losses from the drop in Predictive Oncology's long position.The idea behind Stereotaxis and Predictive Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Predictive Oncology vs. GlucoTrack | Predictive Oncology vs. Sharps Technology | Predictive Oncology vs. Microbot Medical | Predictive Oncology vs. Nexgel Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |